Serum levels of ACE2 are higher in patients with obesity and diabetes

OBJECTIVE: As severity of outcome in COVID‐19 is disproportionately higher among individuals with obesity, smokers, patients with hypertension, kidney disease, chronic pulmonary disease, coronary heart disease (CHD), and/or type 2 diabetes (T2D), serum levels of ACE2, the cellular entry point for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Emilsson, Valur, Gudmundsson, Elias F., Aspelund, Thor, Jonsson, Brynjolfur G., Gudjonsson, Alexander, Launer, Lenore J., Lamb, John R., Gudmundsdottir, Valborg, Jennings, Lori L., Gudnason, Vilmundur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019273/
https://www.ncbi.nlm.nih.gov/pubmed/33841894
http://dx.doi.org/10.1002/osp4.472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019273/
https://www.ncbi.nlm.nih.gov/pubmed/33841894
http://dx.doi.org/10.1002/osp4.472

Ejemplares similares